Advertisement

AIDS and Behavior

, Volume 23, Issue 12, pp 3427–3434 | Cite as

Suicidal Ideation Among Adults Re-engaging in HIV Care in Argentina

  • Lissa N. Mandell
  • Violeta J. Rodriguez
  • Aileen De La Rosa
  • John M. Abbamonte
  • Omar Sued
  • Diego Cecchini
  • Isabel Cassetti
  • Pedro Cahn
  • Stephen M. Weiss
  • Deborah L. JonesEmail author
  • COPA Study Group
Original Paper

Abstract

Argentina has one of the highest suicide rates in Latin America and the Caribbean. Though people living with HIV are at increased risk for suicidal behavior, little research on suicide risk has been conducted among HIV-positive people in this region. This study examined risk factors for suicidal ideation among HIV-infected adults (N = 360) re-engaging in care in Argentina. Overall, 21% of participants reported suicidal ideation in the past week. In adjusted logistic regression models, younger age, increased depressive symptomatology, and drug abuse were associated with suicidal ideation (p < 0.05); decreased motivation for adherence and fewer months since initiating antiretroviral therapy approached significance (p = 0.07). Suicidal ideation was common in this sample of HIV-positive patients in Argentina. Findings highlight the need for routine risk assessment and interventions integrated into the HIV care continuum, addressing depression, substance use, and suicidal behavior.

Keywords

HIV Suicidal ideation Argentina South America Engagement in care 

Resumen

Argentina tiene una de las tasas de suicidio más altas de América Latina y el Caribe. Aunque las personas que viven con el VIH tienen un mayor riesgo de comportamiento suicida, se ha realizado poca investigación sobre el riesgo de suicidio entre las personas con VIH en esta región. Este estudio examinó los factores de riesgo que contribuyen a los pensamientos suicidas entre adultos con VIH (N = 360) quienes están revinculando con el tratamiento en la Argentina. El 21% de los participantes reportaron pensamientos suicidas en la semana pasada. En modelos de regresión logística ajustada, ser más joven, sintomatología depresiva, y el abuso de drogas estuvieron asociados con pensamientos suicidas (p < 0.05). Menos motivación para cumplir con el tratamiento y menos meses desde el inicio del tratamiento antirretroviral se aproximaron a tener una correlación con pensamientos suicidas (p = 0.07). Los pensamientos suicidas fueron prevalentes en este grupo de pacientes con VIH en la Argentina. Los hallazgos resaltan la necesidad de evaluaciones de riesgo e intervenciones integradas para la depresión, el uso de drogas y el comportamiento suicida entre pacientes con VIH.

Palabras clave

VIH pensamientos suicidas Argentina América del Sur compromiso con la atención 

Notes

Acknowledgements

This study was made possible through the efforts of the COPA2 team and the men and women participating. This study was funded by the National Institute of Mental Health, R01MH110242, with support from the Miami Center for AIDS Research through funding from the National Institute of Allergy and Infectious Diseases, P30AI073961. VJR’s work on this manuscript was partially supported by a Ford Foundation Fellowship, administered by the National Academies of Sciences, Engineering, and Medicine.

COPA Study Group (collaborators): Agustina Arguello, Laura Cabrera, Florencia Cahn, Liliana Calanni, Ana Crinejo, Daniel David, Emanuel Dell’Isola, Mariano De Stefano, Fabiana Enjamio, María Inés Figueroa, Marcela Gunning, Sergio Lupo, Carolina Pérez, Héctor Pérez, Rufina Pérez, Claudia Rodriguez, María José Rolon, Alicia Sisto, Natalia Tokumoto, Liliana Trape, Gonzalo Vigo.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–33.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    O’Connor RC, Nock MK. The psychology of suicidal behaviour. Lancet Psychiatr. 2014;1(1):73–85.CrossRefGoogle Scholar
  3. 3.
    Catalan J, Harding R, Sibley E, Clucas C, Croome N, Sherr L. HIV infection and mental health: suicidal behaviour–systematic review. Psychol Health Med. 2011;16(5):588–611.PubMedCrossRefGoogle Scholar
  4. 4.
    Ahmedani BK, Peterson EL, Hu Y, et al. Major physical health conditions and risk of suicide. Am J Prev Med. 2017;53(3):308–15.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Van Orden KA, Witte TK, Cukrowicz KC, Braithwaite SR, Selby EA, Joiner TE Jr. The interpersonal theory of suicide. Psychol Rev. 2010;117(2):575–600.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Van Orden KA, Witte TK, Gordon KH, Bender TW, Joiner TE. Suicidal desire and the capability for suicide: tests of the interpersonal-psychological theory of suicidal behavior among adults. J Consult Clin Psych. 2008;76(1):72–83.CrossRefGoogle Scholar
  7. 7.
    Dabaghzadeh F, Jabbari F, Khalili H, Abbasian L. Associated factors of suicidal thoughts in HIV-positive individuals. Iran J Psychiatr. 2015;10(3):185–91.Google Scholar
  8. 8.
    Passos SM, Souza LD, Spessato BC. High prevalence of suicide risk in people living with HIV: who is at higher risk? AIDS Care. 2014;26(11):1379–82.PubMedCrossRefGoogle Scholar
  9. 9.
    Ogundipe OA, Olagunju AT, Adeyemi JD. Suicidal ideation among attendees of a West African HIV clinic. Arch Suicide Res. 2015;19(1):103–16.PubMedCrossRefGoogle Scholar
  10. 10.
    Kang CR, Bang JH, Cho SI, et al. Suicidal ideation and suicide attempts among human immunodeficiency virus-infected adults: differences in risk factors and their implications. AIDS Care. 2016;28(3):306–13.PubMedCrossRefGoogle Scholar
  11. 11.
    Schlebusch L, Govender RD. Age, gender and suicidal ideation following voluntary HIV counseling and testing. Int J Environ Res Public Health. 2012;9(2):521–30.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V. The prevalence and characteristics of suicidality in HIV/AIDS as seen in an African population in Entebbe district, Uganda. BMC Psychiatr. 2012;12:63.CrossRefGoogle Scholar
  13. 13.
    Bitew H, Andargie G, Tadesse A, Belete A, Fekadu W, Mekonen T. Suicidal ideation, attempt, and determining factors among HIV/AIDS patients, Ethiopia. Depress Res Treat. 2016;2016:8913160.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Badiee J, Moore DJ, Atkinson JH, et al. Lifetime suicidal ideation and attempt are common among HIV+ individuals. J Affect Disord. 2012;136(3):993–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Carrico AW, Johnson MO, Morin SF, et al. Correlates of suicidal ideation among HIV-positive persons. Aids. 2007;21(9):1199–203.PubMedCrossRefGoogle Scholar
  16. 16.
    Wu YL, Yang HY, Wang J, et al. Prevalence of suicidal ideation and associated factors among HIV-positive MSM in Anhui, China. Int J STD AIDS. 2015;26(7):496–503.PubMedCrossRefGoogle Scholar
  17. 17.
    Liu Y, Niu L, Wang M, Chen X, Xiao S, Luo D. Suicidal behaviors among newly diagnosed people living with HIV in Changsha, China. AIDS Care. 2017;29(11):1359–63.PubMedCrossRefGoogle Scholar
  18. 18.
    Nock MK, Borges G, Bromet EJ, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192(2):98–105.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Mascayano F, Irrazabal M, Emilia WD, et al. Suicide in Latin America: a growing public health issue. Revista de la Facultad de Ciencias Médicas. 2016;72(4):9.Google Scholar
  20. 20.
    Teti GL, Rebok F, Grendas LN, Rodante D, Fogola A, Daray FM. Patients hospitalized for suicidal ideation and suicide attempt in a Mental Health Hospital: clinicodemographical features and 6-month follow-up. Vertex. May-Jun. 2014;25(115):203–12.Google Scholar
  21. 21.
    Flores Kanter PE. State of psychological empirical research on suicide in Argentine: A bibliometric study. Interdisciplinaria. 2017;34(1):25–37.Google Scholar
  22. 22.
    Bella ME. Risk factors and behaviors among children and adolescents hospitalized for a suicidal attempt. Rev Med Chil. 2012;140(11):1417–24.PubMedCrossRefGoogle Scholar
  23. 23.
    Matusevich D, Finkelsztein C, Dabi E. Suicide attempts in elderly people. Data from the Hospital Italiano de Buenos Aires. Vertex. 2003;14(52):119–23.PubMedGoogle Scholar
  24. 24.
    Lester D. Suicide and culture. World Cult Psychiatr Res Rev. 2008;2008:51–68.Google Scholar
  25. 25.
    Pando MA, Dolezal C, Marone RO, et al. High acceptability of rapid HIV self-testing among a diverse sample of MSM from Buenos Aires, Argentina. PLoS ONE. 2017;12(7):e0180361.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Rodriguez VJ, Sued O, Cecchini D, et al. Suicidality among nonadherent patients living with HIV in Buenos Aires, Argentina: prevalence and correlates. AIDS Care. 2018;30:1380–7.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    The Well Project. Stigma and Discrimination Against Women Living with HIV. 2018; https://www.thewellproject.org/hiv-information/stigma-and-discrimination-against-women-living-hiv. Accessed April 1, 2019.
  28. 28.
    Rice WS, Turan B, Fletcher FE, et al. A mixed methods study of anticipated and experienced stigma in health care settings among women living with HIV in the United States. AIDS Patient Care STDS. 2019;33(4):184–95.PubMedCrossRefGoogle Scholar
  29. 29.
    Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the scale for suicide ideation. J Consult Clin Psychol. 1979;47(2):343–52.PubMedCrossRefGoogle Scholar
  30. 30.
    Isaac V, Wu CY, McLachlan CS, Lee MB. Associations between health-related self-efficacy and suicidality. BMC Psychiatr. 2018;18(1):126.CrossRefGoogle Scholar
  31. 31.
    Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45(5):394–402.PubMedCrossRefGoogle Scholar
  32. 32.
    Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Sued O, Cassetti I, Cecchini D, et al. Physician-delivered motivational interviewing to improve adherence and retention in care among challenging HIV-infected patients in Argentina (COPA2): study protocol for a cluster randomized controlled trial. Trials. 2018;19(1):396.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Jones DL, Sued O, Cecchini D, et al. Improving adherence to care among “hard to reach” HIV-infected patients in Argentina. AIDS Behav. 2016;20(5):987–97.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Beck AT, Steer RA. Manual for the beck depression inventory. San Antonio, TX: Psychological Corporation; 1993.Google Scholar
  36. 36.
    Bonicatto S, Dew AM, Soria JJ. Analysis of the psychometric properties of the Spanish version of the Beck Depression Inventory in Argentina. Psychiatr Res. 1998;79(3):277–85.CrossRefGoogle Scholar
  37. 37.
    Kalichman SC, Heckman T, Kochman A, Sikkema K, Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv. 2000;51(7):903–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat. 2007;32(2):189–98.PubMedCrossRefGoogle Scholar
  39. 39.
    Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II. Addiction. 1993;88(6):791–804.CrossRefGoogle Scholar
  40. 40.
    Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV treatment adherence self-efficacy scale (HIV-ASES). J Behav Med. 2007;30(5):359–70.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    The LifeWindows Project Team. The LifeWindows Information Motivation Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ). Storrs, Connecticut: Center for Health, Intervention, and Prevention, University of Connecticut; 2006.Google Scholar
  42. 42.
    Ekstrand ML, Chandy S, Heylen E, Steward W, Singh G. Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study. J Acquir Immune Defic Syndr. 2010;53(3):415–6.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941–50.PubMedCrossRefGoogle Scholar
  44. 44.
    Esang M, Ahmed S. A closer look at substance use and suicide. Am J Psychiatr Resid J. 2018;13(6):6–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Lissa N. Mandell
    • 1
  • Violeta J. Rodriguez
    • 1
    • 2
  • Aileen De La Rosa
    • 1
  • John M. Abbamonte
    • 1
  • Omar Sued
    • 3
  • Diego Cecchini
    • 4
  • Isabel Cassetti
    • 4
  • Pedro Cahn
    • 3
  • Stephen M. Weiss
    • 1
  • Deborah L. Jones
    • 1
    • 5
    Email author
  • COPA Study Group
  1. 1.Department of Psychiatry & Behavioral SciencesUniversity of Miami Miller School of MedicineMiamiUSA
  2. 2.Department of PsychologyUniversity of GeorgiaAthensUSA
  3. 3.Fundación HuéspedBuenos AiresArgentina
  4. 4.Helios SaludBuenos AiresArgentina
  5. 5.University of Miami Miller School of MedicineMiamiUSA

Personalised recommendations